1Life Healthcare Inc. (NASDAQ:ONEM) Drops -7.56%, But Further Rally Could Be Imminent – Marketing Sentinel
Home  »  Technologies   »  1Life Healthcare Inc. (NASDAQ:ONEM) Drops -7.56%, ...

1Life Healthcare Inc. (NASDAQ:ONEM) Drops -7.56%, But Further Rally Could Be Imminent

In recent trading session, 1Life Healthcare Inc. (NASDAQ:ONEM) saw 1.13 million shares changing hands at last check today with its beta currently measuring 0. Company’s recent per share price level of $13.81 trading at -$1.13 or -7.56% at last check today assigns it a market valuation of $3.05B. That most recent trading price of ONEM’s stock is at a discount of -333.16% from its 52-week high price of $59.82 and is indicating a premium of 1.01% from its 52-week low price of $13.67. Taking a look at company’s average trading volume of 2.17 million if we extend that period to 3-months.

1Life Healthcare Inc. (NASDAQ:ONEM) trade information

Upright in the red during last session for losing -7.56%, in the last five days ONEM remained trading in the red while hitting it’s week-highest on Friday, 01/07/22 when the stock touched $13.81 price level, adding 18.62% to its value on the day. 1Life Healthcare Inc.’s shares saw a change of -14.97% in year-to-date performance and have moved -11.55% in past 5-day. 1Life Healthcare Inc. (NASDAQ:ONEM) showed a performance of -10.49% in past 30-days.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


1Life Healthcare Inc. (ONEM) estimates and forecasts

Statistics highlight that 1Life Healthcare Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -43.83% of value to its shares in past 6 months, showing an annual growth rate of -110.67% while that of industry is 12.60. Apart from that, the company came lowering its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to decrease by -766.70% in the current quarter and calculating -55.20% decrease in the next quarter. This year revenue growth is estimated to rise 60.90% from the last financial year’s standing.

11 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $218.82 million for the same. And 11 analysts are in estimates of company making revenue of $251.91 million in the next quarter that will end on Mar 2022. Company posted $121.8 million and $121.35 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 79.70% while estimating it to be 107.60% for the next quarter.

ONEM Dividends

1Life Healthcare Inc. is more likely to be releasing its next quarterly report between February 23 and February 28 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

1Life Healthcare Inc. (NASDAQ:ONEM)’s Major holders

Insiders are in possession of 0.92% of company’s total shares while institution are holding 79.03 percent of that, with stock having share float percentage of 79.76%. Investors also watch the number of corporate investors in a company very closely, which is 79.03% institutions for 1Life Healthcare Inc. that are currently holding shares of the company. FMR, LLC is the top institutional holder at ONEM for having 15.1 million shares of worth $305.82 million. And as of Sep 29, 2021, it was holding 7.91% of the company’s outstanding shares.

The second largest institutional holder is Carlyle Group Inc., which was holding about 13.61 million shares on Sep 29, 2021. The number of shares represents firm’s hold over 7.13% of outstanding shares, having a total worth of $275.66 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

On the other hand, ARK ETF Tr-ARK Genomic Revolution ETF and BNY Mellon Small/Mid Cap Growth Fd are the top two Mutual Funds which own company’s shares. As of Oct 30, 2021, the former fund manager was holding 3.59 million shares of worth $77.83 million or 1.88% of the total outstanding shares. The later fund manager was in possession of 2.98 million shares on Sep 29, 2021, making its stake of worth around $60.38 million in the company or a holder of 1.56% of company’s stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts



Download Free eBook For



100% free. stop anytime no spam